{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibnrealhdrsexogqfx4gi4a46qz3kyu3dardg3wx6ppjqtleka2ya",
    "uri": "at://did:plc:yhmwewfk3g3hhkrw2gf4ypna/app.bsky.feed.post/3mer2adoon6w2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigicomyp6knevql6d2r62i5wpnc3yfgcskde24xv5rqkqgxeg47jy"
    },
    "mimeType": "image/jpeg",
    "size": 59497
  },
  "path": "/2026/02/13/in-rare-move-fda-refuses-to-review-modernas-mrna-flu-vaccine/",
  "publishedAt": "2026-02-13T16:00:55.000Z",
  "site": "https://dissentwatch.com",
  "tags": [
    "Uncategorized"
  ],
  "textContent": "The FDA has delivered an unusually blunt rebuke to Moderna, refusing even to review the company’s application for an mRNA-based flu vaccine. In a February 3rd letter, the agency issued what’s known as a “refuse-to-file” decision, telling Moderna that its submission failed a basic requirement: it did not include an “adequate and well-controlled” clinical trial. […]",
  "title": "In Rare Move, FDA Refuses to Review Moderna’s mRNA Flu Vaccine"
}